Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019 · The Lancet · 2,820 citations
https://doi.org/10.1016/s0140-6736(19)31149-3
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
54
Citations
2
h-index
1
i10-index
Pablo Mora is an academic researcher. The author has contributed to research in topics: Libraries, Manuscripts, and Books & Comparative Literary Analysis and Criticism & Spanish Literature and Culture Studies. The author has an h-index of 2, co-authored 40 publications.
https://doi.org/10.1016/s0140-6736(19)31149-3
https://doi.org/10.1016/s0140-6736(19)31150-x
Click to start Chat